Roche is moving towards a comprehensive new haemostasis testing portfolio with a number of industry firsts and innovative applications for early disease detection and monitoring. From easy-to-use, low-volume analysers for professional and self-monitoring, to systems meeting the high-efficiency requirements of the laboratory, Roche's products provide high-quality results and offer outstanding productivity while reducing complexity.
The new generation of testing solutions is driven by a commitment to deliver high-quality, cost-effective solutions capable of addressing the current and future testing needs of a wide range of customers.